Storm Therapeutics raised €28M in a Series B round in Dec 2022. The company is based in Cambridge, UK. Investors in the round: Cambridge Innovation Capital, Fast Track Initiative, IP Group PLC and 5 others. Data as of 6 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
